534 related articles for article (PubMed ID: 12637112)
41. Pharmacotherapy of obesity.
Finer N
Best Pract Res Clin Endocrinol Metab; 2002 Dec; 16(4):717-42. PubMed ID: 12468417
[TBL] [Abstract][Full Text] [Related]
42. Head-to-head studies evaluating efficacy of pharmaco-therapy for obesity: a systematic review and meta-analysis.
Neovius M; Johansson K; Rössner S
Obes Rev; 2008 Sep; 9(5):420-7. PubMed ID: 18208467
[TBL] [Abstract][Full Text] [Related]
43. [Drug treatment of obesity].
Svendsen OL; Toubro S; Breum L; Bruun JM; Astrup AV
Ugeskr Laeger; 2006 Jan; 168(2):163-7. PubMed ID: 16403342
[TBL] [Abstract][Full Text] [Related]
44. Orlistat: a review of its use in the management of obesity.
Henness S; Perry CM
Drugs; 2006; 66(12):1625-56. PubMed ID: 16956313
[TBL] [Abstract][Full Text] [Related]
45. Effects of sibutramine plus orlistat in obese women following 1 year of treatment by sibutramine alone: a placebo-controlled trial.
Wadden TA; Berkowitz RI; Womble LG; Sarwer DB; Arnold ME; Steinberg CM
Obes Res; 2000 Sep; 8(6):431-7. PubMed ID: 11011909
[TBL] [Abstract][Full Text] [Related]
46. A systematic review and mixed treatment comparison of pharmacological interventions for the treatment of obesity.
Gray LJ; Cooper N; Dunkley A; Warren FC; Ara R; Abrams K; Davies MJ; Khunti K; Sutton A
Obes Rev; 2012 Jun; 13(6):483-98. PubMed ID: 22288431
[TBL] [Abstract][Full Text] [Related]
47. Orlistat.
Wong NN; Cheng-Lai A
Heart Dis; 2000; 2(2):174-81. PubMed ID: 11728255
[TBL] [Abstract][Full Text] [Related]
48. Orlistat: a review of its use in the management of obesity.
Hvizdos KM; Markham A
Drugs; 1999 Oct; 58(4):743-60. PubMed ID: 10551441
[TBL] [Abstract][Full Text] [Related]
49. Orlistat, sibutramine, or combination therapy: which performs better on waist circumference in relation with body mass index in obese patients?
Aydin N; Topsever P; Kaya A; Karasakal M; Duman C; Dağar A
Tohoku J Exp Med; 2004 Mar; 202(3):173-80. PubMed ID: 15065643
[TBL] [Abstract][Full Text] [Related]
50. [Weight loss via drug therapy].
Wirth A
Internist (Berl); 2003 Mar; 44(3):359-62, 363-6. PubMed ID: 12731423
[TBL] [Abstract][Full Text] [Related]
51. Orlistat in the treatment of obesity.
Ballinger A
Expert Opin Pharmacother; 2000 May; 1(4):841-7. PubMed ID: 11249520
[TBL] [Abstract][Full Text] [Related]
52. An assessment of the safety and efficacy of sibutramine, an anti-obesity drug with a novel mechanism of action.
Nisoli E; Carruba MO
Obes Rev; 2000 Oct; 1(2):127-39. PubMed ID: 12119986
[TBL] [Abstract][Full Text] [Related]
53. Orlistat: current status in clinical therapeutics.
McClendon KS; Riche DM; Uwaifo GI
Expert Opin Drug Saf; 2009 Nov; 8(6):727-44. PubMed ID: 19998527
[TBL] [Abstract][Full Text] [Related]
54. Pharmacotherapeutic options for overweight adolescents.
Dunican KC; Desilets AR; Montalbano JK
Ann Pharmacother; 2007 Sep; 41(9):1445-55. PubMed ID: 17652127
[TBL] [Abstract][Full Text] [Related]
55. Long-term persistence with orlistat and sibutramine in a population-based cohort.
Padwal R; Kezouh A; Levine M; Etminan M
Int J Obes (Lond); 2007 Oct; 31(10):1567-70. PubMed ID: 17420781
[TBL] [Abstract][Full Text] [Related]
56. Efficacy of weight loss drugs on obesity and cardiovascular risk factors in obese adolescents: a meta-analysis of randomized controlled trials.
Czernichow S; Lee CM; Barzi F; Greenfield JR; Baur LA; Chalmers J; Woodward M; Huxley RR
Obes Rev; 2010 Feb; 11(2):150-8. PubMed ID: 19573052
[TBL] [Abstract][Full Text] [Related]
57. Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement.
Avenell A; Broom J; Brown TJ; Poobalan A; Aucott L; Stearns SC; Smith WC; Jung RT; Campbell MK; Grant AM
Health Technol Assess; 2004 May; 8(21):iii-iv, 1-182. PubMed ID: 15147610
[TBL] [Abstract][Full Text] [Related]
58. Long term pharmacotherapy for obesity and overweight: updated meta-analysis.
Rucker D; Padwal R; Li SK; Curioni C; Lau DC
BMJ; 2007 Dec; 335(7631):1194-9. PubMed ID: 18006966
[TBL] [Abstract][Full Text] [Related]
59. Who will lose weight on sibutramine and orlistat? Psychological correlates for treatment success.
Elfhag K; Finer N; Rössner S
Diabetes Obes Metab; 2008 Jun; 10(6):498-505. PubMed ID: 17593239
[TBL] [Abstract][Full Text] [Related]
60. Effects of sibutramine and orlistat on mood in obese and overweight subjects: a randomised study.
Kiortsis DN; Tsouli S; Filippatos TD; Konitsiotis S; Elisaf MS
Nutr Metab Cardiovasc Dis; 2008 Mar; 18(3):207-10. PubMed ID: 17570651
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
